脳腫瘍の診断と治療市場：治療、診断、タイプ別-2025-2030年の世界予測

脳腫瘍の診断と治療市場は、2023年に16億9,000万米ドルと評価され、2024年には18億米ドルに達すると予測され、CAGR 6.85％で成長し、2030年には26億9,000万米ドルに達すると予測されています。

脳腫瘍の診断と治療市場の範囲は広く、画像技術、外科手術、放射線療法、新規薬剤開拓など、脳腫瘍を検出・管理するための技術や方法を包含しています。その必要性は、高齢化や環境要因による有病率の増加により、より効果的で侵襲性の低い診断・治療技術への需要が高まっている神経疾患への対応が急務となっていることに起因しています。最終用途は主に神経学と腫瘍学を専門とする医療従事者です。主な成長要因としては、MRIやCTスキャンなどの医用画像技術の進歩に加え、治療効果や患者の転帰を高める標的治療や個別化医療アプローチの革新が挙げられます。また、早期診断の精度を向上させるために人工知能と画像技術を組み合わせることや、遺伝子治療や免疫治療のようなバイオテクノロジーによるソリューションの開拓は、市場の大きな成長を約束するものです。このような機会を活用するため、企業は研究開発への投資、研究機関との協力関係の促進、新規治療法の市場投入までの時間を短縮するための規制機関との関わりを持つことが推奨されます。

同市場は、主に治療費の高さ、規制の枠組みの厳しさ、新しい治療法の迅速な開発を妨げる脳の病態生理の複雑さといった制約に直面しています。さらに、新技術について開業医を教育し、患者の信頼を得るという課題も存在します。革新的な研究分野としては、非侵襲的診断法の探求、最先端の遺伝子プロファイリング、リキッドバイオプシー技術、ドラッグデリバリーを改善するための血液脳関門透過性向上技術などが挙げられます。競合情勢を理解することは極めて重要です。というのも、市場は新興企業や既存企業が絶えず製品ラインを進化させており、非常にダイナミックだからです。精密医療とリアルタイムのデータ分析に注力することで、進化する患者のニーズと治療プロトコールに関する重要な洞察を得ることができます。

市場力学：急速に進化する脳腫瘍の診断と治療市場の主要市場インサイトを公開

脳腫瘍の診断と治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 脳腫瘍およびその他の神経疾患の増加
  • 患者の生存率を向上させ、新しい個別化治療を開発するための早期診断の必要性
  • 脳細胞診断装置の技術進歩の増加
• 市場抑制要因
  • 非特異的な薬剤の入手可能性とジェネリック医薬品の使用増加
  • 生物学的に攻撃的な腫瘍の治療に伴う独特の懸念
• 市場機会
  • 脳腫瘍治療を急増させる緩和ケアと臨床試験
  • 治療のための新規薬剤や治療法の発明
• 市場の課題
  • 新興国における診断・治療費の高騰

ポーターの5つの力：脳腫瘍の診断と治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脳腫瘍の診断と治療市場における外部からの影響の把握

外部マクロ環境要因は、脳腫瘍の診断と治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脳腫瘍の診断と治療市場における競合情勢の把握

脳腫瘍の診断と治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脳腫瘍の診断と治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脳腫瘍の診断と治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脳腫瘍の診断と治療市場における成功への道筋を描く

脳腫瘍の診断と治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 脳腫瘍やその他の神経疾患の発生率の上昇
    • 患者の生存率を改善し、新たな個別化治療を開発するためには早期診断が必要である
    • 脳細胞診断装置の技術進歩の加速
  • 抑制要因
    • 非特異的な薬剤の利用可能性とジェネリック医薬品の使用の増加
    • 生物学的に攻撃的な腫瘍の治療に関連する特有の懸念
  • 機会
    • 緩和ケアと臨床試験で脳腫瘍治療を加速
    • 治療のための新しい薬剤や治療法の発明
  • 課題
    • 新興国における診断と治療の高額なコスト
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脳腫瘍の診断と治療市場治療別

• 化学療法
• 免疫療法
• 放射線治療
• 放射線手術
• 手術
• 標的薬物療法

第7章 脳腫瘍の診断と治療市場診断別

• CTスキャン
• 脳波
• 分子検査
• MRI
• PET-CTスキャン

第8章 脳腫瘍の診断と治療市場：タイプ別

• 原発性脳腫瘍
• 二次性脳腫瘍

第9章 南北アメリカの脳腫瘍の診断と治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の脳腫瘍の診断と治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脳腫瘍の診断と治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amgen Inc.
• AstraZeneca PLC
• Canon Medical Systems Corporation
• Carestream Health, Inc.
• Eisai Co., Ltd.
• Elekta AB
• GE Healthcare
• Hitachi Medical Systems
• Koninklijke Philips N.V.
• Merck & Co., Inc.
• Pfizer Inc.
• Shimadzu Corporation
• Siemens Healthineers AG
• Varian Medical Systems, Inc.

LIST OF FIGURES

• FIGURE 1. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TARGETED DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY BRAIN TUMOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY BRAIN TUMOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 52. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 55. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 107. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 119. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 122. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Brain Tumor Diagnosis & Treatment Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 2.69 billion by 2030.

The scope of the Brain Tumor Diagnosis & Treatment market is expansive, encompassing technologies and methods for detecting and managing brain tumors, including imaging techniques, surgical procedures, radiation therapies, and novel drug developments. Its necessity stems from the urgent need to address neurological diseases, with increasing prevalence due to aging populations and environmental factors driving demand for more effective and less invasive diagnostic and therapeutic technologies. In terms of application, this market spans from hospitals and diagnostic centers to research institutions, with end-use primarily focusing on medical professionals specializing in neurology and oncology. Key growth factors include advancements in medical imaging technologies, such as MRI and CT scans, along with innovation in targeted therapies and personalized medicine approaches that enhance treatment efficacy and patient outcomes. Latest potential opportunities can be found in combining artificial intelligence with imaging technologies to improve accuracy in early diagnosis, and the development of biotechnological solutions like gene therapies and immunotherapies which promise significant market growth. To capitalize on these opportunities, companies are recommended to invest in research and development, foster collaborations with research institutes, and engage with regulatory bodies to expedite the time-to-market for new treatments.

The market does face limitations, primarily due to the high cost of treatment, stringent regulatory frameworks, and the complex nature of brain pathophysiology that hinders rapid development of new therapies. Moreover, there exists a challenge in educating practitioners about new technologies and gaining patient trust. Innovative areas for research include exploring non-invasive diagnostic methods, cutting-edge genetic profiling, liquid biopsy technologies, and techniques for enhancing blood-brain barrier permeability to improve drug delivery. Understanding the competitive landscape is crucial, as the market is highly dynamic with emerging players and established companies continually evolving their product lines. Focus on precision medicine and real-time data analytics can offer significant insights into evolving patient needs and treatment protocols, crucial for thriving in this challenging yet promising market arena.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Tumor Diagnosis & Treatment Market

The Brain Tumor Diagnosis & Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of brain cancer and other neurological disorders
  • Need for early diagnostic to improve the survival rate of patients and to develop new personalized treatments
  • Increasing technological advancement in brain cells diagnostics devices
• Market Restraints
  • Availability of nonspecific drugs and growing use of generics treatments
  • Unique concern associated with the treatment of biologically aggressive tumors
• Market Opportunities
  • Palliative care and clinical trials to surge the brain tumor treatment
  • Inventions of novel drugs and therapies for the treatment
• Market Challenges
  • Heavy cost of diagnosis and treatment in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Brain Tumor Diagnosis & Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Tumor Diagnosis & Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Tumor Diagnosis & Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Tumor Diagnosis & Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Tumor Diagnosis & Treatment Market

A detailed market share analysis in the Brain Tumor Diagnosis & Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Tumor Diagnosis & Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Tumor Diagnosis & Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Tumor Diagnosis & Treatment Market

A strategic analysis of the Brain Tumor Diagnosis & Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Tumor Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Canon Medical Systems Corporation, Carestream Health, Inc., Eisai Co., Ltd., Elekta AB, GE Healthcare, Hitachi Medical Systems, Koninklijke Philips N.V., Merck & Co., Inc., Pfizer Inc., Shimadzu Corporation, Siemens Healthineers AG, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Tumor Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Chemotherapy, Immunotherapy, Radiation Therapy, Radiosurgery, Surgery, and Targeted Drug Therapy.
• Based on Diagnosis, market is studied across CT Scan, EEG, Molecular Testing, MRI, and PET-CT Scan.
• Based on Type, market is studied across Primary Brain Tumor and Secondary Brain Tumor.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of brain cancer and other neurological disorders
    • 5.1.1.2. Need for early diagnostic to improve the survival rate of patients and to develop new personalized treatments
    • 5.1.1.3. Increasing technological advancement in brain cells diagnostics devices
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of nonspecific drugs and growing use of generics treatments
    • 5.1.2.2. Unique concern associated with the treatment of biologically aggressive tumors
  • 5.1.3. Opportunities
    • 5.1.3.1. Palliative care and clinical trials to surge the brain tumor treatment
    • 5.1.3.2. Inventions of novel drugs and therapies for the treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Heavy cost of diagnosis and treatment in emerging economies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Brain Tumor Diagnosis & Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Chemotherapy
• 6.3. Immunotherapy
• 6.4. Radiation Therapy
• 6.5. Radiosurgery
• 6.6. Surgery
• 6.7. Targeted Drug Therapy

7. Brain Tumor Diagnosis & Treatment Market, by Diagnosis

• 7.1. Introduction
• 7.2. CT Scan
• 7.3. EEG
• 7.4. Molecular Testing
• 7.5. MRI
• 7.6. PET-CT Scan

8. Brain Tumor Diagnosis & Treatment Market, by Type

• 8.1. Introduction
• 8.2. Primary Brain Tumor
• 8.3. Secondary Brain Tumor

9. Americas Brain Tumor Diagnosis & Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Brain Tumor Diagnosis & Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Brain Tumor Diagnosis & Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amgen Inc.
• 2. AstraZeneca PLC
• 3. Canon Medical Systems Corporation
• 4. Carestream Health, Inc.
• 5. Eisai Co., Ltd.
• 6. Elekta AB
• 7. GE Healthcare
• 8. Hitachi Medical Systems
• 9. Koninklijke Philips N.V.
• 10. Merck & Co., Inc.
• 11. Pfizer Inc.
• 12. Shimadzu Corporation
• 13. Siemens Healthineers AG
• 14. Varian Medical Systems, Inc.